Kuros Biosciences' market value is the price at which a share of Kuros Biosciences trades on a public exchange. It measures the collective expectations of Kuros Biosciences AG investors about its performance. Kuros Biosciences is trading at 32.00 as of the 12th of February 2026. This is a 0.28 percent increase since the beginning of the trading day. The stock's lowest day price was 32.0. With this module, you can estimate the performance of a buy and hold strategy of Kuros Biosciences AG and determine expected loss or profit from investing in Kuros Biosciences over a given investment horizon. Check out Kuros Biosciences Correlation, Kuros Biosciences Volatility and Kuros Biosciences Performance module to complement your research on Kuros Biosciences.
It's important to distinguish between Kuros Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Kuros Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Kuros Biosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Kuros Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kuros Biosciences' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kuros Biosciences.
0.00
11/14/2025
No Change 0.00
0.0
In 3 months and 1 day
02/12/2026
0.00
If you would invest 0.00 in Kuros Biosciences on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Kuros Biosciences AG or generate 0.0% return on investment in Kuros Biosciences over 90 days. Kuros Biosciences is related to or competes with CStone Pharmaceuticals, SanBio Company, Pharma Mar, PeptiDream, Pharming Group, Neuren Pharmaceuticals, and China Traditional. Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development of biopharmaceutical... More
Kuros Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kuros Biosciences' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kuros Biosciences AG upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kuros Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kuros Biosciences' standard deviation. In reality, there are many statistical measures that can use Kuros Biosciences historical prices to predict the future Kuros Biosciences' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kuros Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Kuros Biosciences has Sharpe Ratio of -0.1, which conveys that the firm had a -0.1 % return per unit of risk over the last 3 months. Kuros Biosciences exposes nineteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kuros Biosciences' Risk Adjusted Performance of (0.08), mean deviation of 0.5595, and Standard Deviation of 1.69 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.3, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Kuros Biosciences are expected to decrease at a much lower rate. During the bear market, Kuros Biosciences is likely to outperform the market. At this point, Kuros Biosciences has a negative expected return of -0.18%. Please make sure to verify Kuros Biosciences' information ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Kuros Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation
-0.7
Very good reverse predictability
Kuros Biosciences AG has very good reverse predictability. Overlapping area represents the amount of predictability between Kuros Biosciences time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kuros Biosciences price movement. The serial correlation of -0.7 indicates that around 70.0% of current Kuros Biosciences price fluctuation can be explain by its past prices.
Other Information on Investing in Kuros Pink Sheet
Kuros Biosciences financial ratios help investors to determine whether Kuros Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kuros with respect to the benefits of owning Kuros Biosciences security.